Category Archives: Yaz & the FDA

Current Yasmin and Yaz Label Warnings Are Inadequate

Seated around a U-shaped configuration of tables sat the 26 member FDA Advisory Committee — all scientists or physicians gathered to discuss the risks of birth control pills containing DRSP. They focused on the risks as described in recent studies, … Continue reading

Posted in Yaz & the FDA | Tagged , , | Comments Off

More Evidence that Yaz carries an increased risk of VTE

  The FDA posted the results of its much anticipated large retrospective study about the risk of venous thrombotic events (VTEs) and  newer contraceptives containing drosperinone (DRSP)  such as Yasmin, Yaz and Beyaz. The FDA reports “In adjusted analyses, DRSP … Continue reading

Posted in Yaz & the FDA | Tagged , | Comments Off

FDA Safety Committees will examine the risks of Yasmin/Yaz/Beyaz as compared to levonorgestrel birth control pills.

Two FDA Safety Committees will hold public meetings about the risks of Yaz on December 8, 2011. The two committees to meet are (1) the 13-member Reproductive Health Drugs Advisory Committee and (2) the 13-member Drug Safety and Risk Management … Continue reading

Posted in Yaz & the FDA, Yaz Science & Chemistry | Tagged , | Comments Off

FDA Remains Inconclusive Regarding Drospirenone Study Results

The FDA has communicated a luke warm statement about the safety of birth control pills containing drospirenone, stating that it “has not yet reached a conclusion and remains concerned.” Consumers continue to await the final results of the FDA-funded study … Continue reading

Posted in Yaz & the FDA | Tagged , | Comments Off

FDA Investigates Yaz Blood Clot Risks

It’s been more than five years since the The Food and Drug Administration (FDA) first warned that Bayer was exaggerating the benefits and minimizing the risks associated with the synthetic hormone drospirenone found in the leading birth control pills Yaz … Continue reading

Posted in Yaz & the FDA | Tagged , , , | Comments Off

The First Warning: FDA Warns Makers of Yasmin

You might have read about some of the warning letters the FDA sent to the makers of Yaz and Yasmin for misleading advertising – maybe you’ve even seen the Yaz commercial that clarifies the risks of Yaz at the FDA’s … Continue reading

Posted in Yaz & the FDA, Yaz Marketing and Warnings | Tagged | Comments Off

NPR Reports on Yaz and Yasmin Lawsuits, Birth Control Pill Risks

As Bayer Pharmaceuticals launches another birth control pill known as Natazia, controversy continues over its top-selling pill, Yaz. National Public Radio reported today about the risks of oral contraceptives, highlighting the story of Katie Anderson, a teenage girl who suffered … Continue reading

Posted in Yaz & the FDA, Yaz Lawsuits, Yaz Marketing and Warnings | Tagged , , | Comments Off

FDA Catches On: Drug Companies Mislead Doctors

Doctors rely on drug company representatives for information about a drug’s risks and benefits. The information that the drug company provides to the doctors is supposed to be accurate and truthful. Unfortunately, as I wrote here, the representatives sometimes understate … Continue reading

Posted in Featured, Yaz & the FDA | Comments Off

Yaz in the News Again

Claudia Coffey of Fox 5 in Washington D.C. just reported on a story about another young woman, Jessica, who suffered from a blood clot in her leg after taking Yaz. Jessica says that her leg swelled up about twice its … Continue reading

Posted in Women's Stories, Yaz & the FDA, Yaz Lawsuits, Yaz Side Effects | Tagged | Comments Off

A Closer Look at the Yaz Commercials and Marketing Campaign

I recently stumbled across a story about Yaz describing another one of its clever advertising campaigns. Bayer Pharmaceuticals, the manufacturer of Yaz, hired Lo Bosworth, a young actress on the popular MTV reality show "the Hills" to be the new … Continue reading

Posted in Yaz & the FDA, Yaz Marketing and Warnings | Tagged | Comments Off
Page 1 of 212